Table 2.
Model of possible excess suicides in 2002 compared to 1991 as a result of increased antidepressant prescribing (assumes findings from paediatric trials apply to adults and additional assumptions listed in text)
| Total | Male | Female | |
|---|---|---|---|
| No of extra antidepressant prescriptions issued in England in 2002 compared with 1991 (Department of Health)* | 17 386 000 | 5 795 000 | 11 591 000 |
| Additional person years exposed to antidepresants in 2002 compared to 1991† | 1 381 000 | 460 000 | 921 000 |
| Suicide rate in primary care treated depression (based on mean one year follow up)16‡ | 85/100 000/year | 127.5/100 000/year | 42.5/100 000/year |
| No of suicides among people receiving antidepressants§ | 586 | 391 | |
| No of excess suicides¶ | 586−(586/1.66)=233 | 391−(391/1.66)=155 |
Figures for males and females based on assumption that ratio of males:females prescribed antidepressants is 1:2.1
Assumes mean duration of antidepressant prescription is 29 days31 and all dispensed prescriptions are taken in their entirety by patients (No of extra prescriptions×29/365).
Assuming ratio of male:female suicide rates among people taking antidepressants is the same as that for general population suicide rates: 3:1.w1 This is in keeping with the relative risk of suicide of 2.8 in males receiving antidepressants compared with females in Jick et al.16
Additional person years of prescriptions×annual suicide rate.
Assuming relative risk associated with antidepressant prescribing is 1.66 (see table 1).